Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextEra Energy
NEE
|
+$122M |
| 2 |
Gilead Sciences
GILD
|
+$122M |
| 3 |
DTE Energy
DTE
|
+$121M |
| 4 |
Ameren
AEE
|
+$118M |
| 5 |
AGN
Allergan plc
AGN
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dominion Energy
D
|
+$125M |
| 2 |
HES
Hess
HES
|
+$101M |
| 3 |
BHI
Baker Hughes
BHI
|
+$84M |
| 4 |
ELN
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
|
+$79.9M |
| 5 |
Cheniere Energy
LNG
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.31% |
| 2 | Energy | 11.61% |
| 3 | Utilities | 8.18% |
| 4 | Financials | 7.58% |
| 5 | Consumer Discretionary | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
CALL
CNX Resources
CNX
$5.38B
| $12.8M | 0.04% |
405,120
-231,600
| -36% | -$7.08M |
|
552
Elevance Health
ELV
$86.9B
| $12.8M | 0.04% |
138,541
+108,315
| +358% | +$9.62M |
|
553
Pacific Biosciences
PACB
$420M
| $12.8M | 0.04% |
2,446,147
+332,713
| +16% | +$1.53M |
|
554
Hershey
HSY
$37.5B
| $12.8M | 0.04% |
131,560
-127,599
| -49% | -$12.3M |
|
555
Trip.com Group
TCOM
$29B
| $12.8M | 0.04% |
515,032
-454,964
| -47% | -$11.9M |
|
|
AXLL
556
DELISTED
AXIALL CORP COM STK (DE)
AXLL
| $12.8M | 0.04% |
269,050
+73,718
| +38% | +$3.17M |
|
557
Louisiana-Pacific
LPX
$5.12B
| $12.7M | 0.04% |
688,676
+491,167
| +249% | +$8.36M |
|
558
Matador Resources
MTDR
$7.22B
| $12.7M | 0.04% |
682,994
-151,714
| -18% | -$2.98M |
|
|
ARPI
559
DELISTED
AMERICAN RESIDENTIAL PPTYS INC COM
ARPI
| $12.7M | 0.04% |
740,542
+381,705
| +106% | +$6.6M |
|
560
CALL
Ulta Beauty
ULTA
$22.4B
| $12.7M | 0.04% |
131,200
+119,400
| +1,012% | +$14M |
|
561
Orthofix Medical
OFIX
$408M
| $12.7M | 0.04% |
554,499
+373,092
| +206% | +$7.8M |
|
562
Xylem
XYL
$26.5B
| $12.6M | 0.04% |
363,582
+339,380
| +1,402% | +$10.9M |
|
563
Jazz Pharmaceuticals
JAZZ
$16.5B
| $12.6M | 0.04% |
99,291
+4,845
| +5% | +$501K |
|
|
FRX
564
CALL
DELISTED
FOREST LABORATORIES INC
FRX
| $12.6M | 0.04% |
+209,100
| New | +$10.5M |
|
|
WCC
565
WESCO International
WCC
$17B
| $12.5M | 0.04% |
137,778
+22,213
| +19% | +$1.85M |
|
566
PUT
Amgen
AMGN
$238B
| $12.5M | 0.04% |
109,700
-2,200
| -2% | -$250K |
|
567
Eastman Chemical
EMN
$8.47B
| $12.5M | 0.04% |
155,008
-430,522
| -74% | -$33.4M |
|
|
WFT
568
CALL
DELISTED
Weatherford International plc
WFT
| $12.5M | 0.04% |
804,600
+400,100
| +99% | +$6.36M |
|
569
PUT
Viatris
VTRS
$18.7B
| $12.4M | 0.04% |
+286,200
| New | +$11.8M |
|
570
Encompass Health
EHC
$11.9B
| $12.4M | 0.04% |
+468,069
| New | +$13M |
|
571
Williams-Sonoma
WSM
$28B
| $12.4M | 0.04% |
+425,258
| New | +$11.9M |
|
572
Charles River Laboratories
CRL
$14.1B
| $12.4M | 0.04% |
233,611
-155,186
| -40% | -$7.79M |
|
|
ROSE
573
DELISTED
ROSETTA RESOURCES INC
ROSE
| $12.4M | 0.04% |
257,258
-234,015
| -48% | -$12.6M |
|
574
Parker-Hannifin
PH
$126B
| $12.3M | 0.04% |
+95,961
| New | +$11.2M |
|
575
Nelnet
NNI
$4.55B
| $12.3M | 0.04% |
292,790
-156,051
| -35% | -$6.58M |
|
Similar funds
Israel Englander's Q4 2013 Portfolio in Review
As of Q4 2013, Israel Englander held 4,194 positions worth $31.7B, up 2% from $31.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander withdrew a net $1.71B in Q4 2013, closing 788 positions and reducing 1,165 holdings. Its most notable exit was ELAN CORP ADS(RP1 ORD4IRISH PN, an estimated $79.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.5% a quarter earlier, followed by Energy and Utilities.
Against the trend, Israel Englander opened a new position in Crown Holdings worth $64.3M.
- Israel Englander's largest Q4 2013 buy was Crown Holdings: 1,441,595 shares worth $64.3M.
- Israel Englander added most to NextEra Energy in Q4 2013, an estimated $122M increase.
- Israel Englander's biggest Q4 2013 reduction was Dominion Energy, cutting an estimated $125M.
- Israel Englander fully exited ELAN CORP ADS(RP1 ORD4IRISH PN in Q4 2013, selling an estimated $79.9M.
- Israel Englander's ten largest holdings make up 14% of its $31.7B portfolio in Q4 2013.
- Israel Englander opened 937 new positions and closed 788 in Q4 2013.
- Israel Englander's portfolio value rose 2% quarter-over-quarter to $31.7B.
Based on Millennium Management's 13F filing for Q4 2013, filed 14 Feb 2014.